#### Covid-19 therapy

Parameter Case Report Form and Response Options

Pharmacological therapy for Covid-19 | |
---|---|

Antipyretics | ☐ |

Corticosteroids | ☐ |

Atazanavir | ☐ |

Darunavir | ☐ |

Chloroquine phosphate | ☐ |

Hydroxychloroquine | ☐ |

Ivermectin | ☐ |

Lopinavir/ritonavir | ☐ |

Ganciclovir | ☐ |

Oseltamivir | ☐ |

Remdesivir | ☐ |

Ribavirin | ☐ |

Camostat | ☐ |

Favipiravir | ☐ |

Convalescent plasma | ☐ |

Steroids (> 0.5 mg/kg prednisone equivalents) | ☐ |

Steroids (<= 0.5 mg/kg prednisone equivalents) | ☐ |

Tocilizumab | ☐ |

Sarilumab | ☐ |

CNI or mTor inhibitors (e.g. cyclosporin A, tacrolimus, sirolimus, everolimus) | ☐ |

Anti-TNF-alpha inhibitors (e.g. adalimumab, etanercept) | ☐ |

Il1-receptor antangonists | ☐ |

Ruxolitinib | ☐ |

Colchicine | ☐ |

Interferone (any) | ☐ |

25-Hydroxyvitamin D | ☐ |

Zinc | ☐ |

Other | ☐ |

This profile of a FHIR MedicationStatement is derived from the MedicationStatement-profile of the Medical Informatics Initiative (MII).

Use *MedicationStatement.medication[x]:medicationCodeableConcept* to code the case parameter form response options.

**Profile - Pharmacological Therapy**

Canonical: https://www.netzwerk-universitaetsmedizin.de/fhir/StructureDefinition/pharmacological-therapy

**Snapshot**

MedicationStatement | I | MedicationStatement | |

identifier | Σ | 0..* | Identifier |

basedOn | Σ I | 0..* | Reference(MedicationRequest | CarePlan | ServiceRequest) |

partOf | S Σ I | 0..* | Reference(MedicationAdministration | MedicationDispense | MedicationStatement | Procedure | Observation) |

status | S Σ ?! | 1..1 | codeBinding |

statusReason | 0..* | CodeableConcept | |

category | Σ | 0..1 | CodeableConceptBinding |

medication[x] | S Σ | 1..1 | |

medicationCodeableConcept | CodeableConcept | ||

coding | Σ | 1..* | Coding |

atcClassDe | Σ | 0..* | CodingBinding |

system | Σ | 1..1 | uri |

version | Σ | 0..1 | string |

code | Σ | 1..1 | code |

display | Σ | 0..1 | string |

userSelected | Σ | 0..1 | boolean |

ops | Σ | 0..* | CodingBinding |

system | Σ | 1..1 | uri |

version | Σ | 0..1 | string |

code | Σ | 1..1 | code |

display | Σ | 0..1 | string |

userSelected | Σ | 0..1 | boolean |

snomed | Σ | 0..* | CodingBinding |

system | Σ | 1..1 | uri |

version | Σ | 0..1 | string |

code | Σ | 1..1 | code |

display | Σ | 0..1 | string |

userSelected | Σ | 0..1 | boolean |

other | Σ | 0..* | CodingBinding |

system | Σ | 1..1 | uri |

version | Σ | 0..1 | string |

code | Σ | 1..1 | code |

display | Σ | 0..1 | string |

userSelected | Σ | 0..1 | boolean |

text | Σ | 0..1 | string |

subject | S Σ I | 1..1 | MII-Reference(Patient | Group) |

context | S Σ I | 0..1 | Reference(Encounter | EpisodeOfCare) |

effective[x] | S Σ | 1..1 | |

effectiveDateTime | dateTime | ||

effectivePeriod | Period | ||

dateAsserted | Σ | 0..1 | dateTime |

informationSource | I | 0..1 | Reference(Patient | Practitioner | PractitionerRole | RelatedPerson | Organization) |

derivedFrom | I | 0..* | Reference(Resource) |

reasonCode | 0..* | CodeableConcept | |

reasonReference | S I | 0..* | Reference(Condition | Observation | DiagnosticReport) |

note | 0..* | Annotation | |

dosage | S | 0..* | Dosage |

sequence | Σ | 0..1 | integer |

text | S Σ | 0..1 | string |

additionalInstruction | Σ | 0..* | CodeableConcept |

patientInstruction | Σ | 0..1 | string |

timing | S Σ | 0..1 | Timing |

asNeeded[x] | Σ | 0..1 | |

asNeededBoolean | boolean | ||

asNeededCodeableConcept | CodeableConcept | ||

site | S Σ | 0..1 | CodeableConcept |

coding | S Σ | 0..* | Coding |

SNOMED | Σ | 0..* | Coding |

system | S Σ | 1..1 | uri |

version | Σ | 0..1 | string |

code | S Σ | 1..1 | code |

display | Σ | 0..1 | string |

userSelected | Σ | 0..1 | boolean |

text | Σ | 0..1 | string |

route | S Σ | 0..1 | CodeableConcept |

coding | S Σ | 0..* | Coding |

EDQM | S Σ | 0..* | CodingBinding |

system | S Σ | 1..1 | uri |

version | Σ | 0..1 | string |

code | S Σ | 1..1 | code |

display | Σ | 0..1 | string |

userSelected | Σ | 0..1 | boolean |

SNOMED | S Σ | 0..* | Coding |

system | S Σ | 1..1 | uri |

version | Σ | 0..1 | string |

code | S Σ | 1..1 | code |

display | Σ | 0..1 | string |

userSelected | Σ | 0..1 | boolean |

text | Σ | 0..1 | string |

method | Σ | 0..1 | CodeableConcept |

doseAndRate | S Σ | 0..* | Element |

type | Σ | 0..1 | CodeableConcept |

dose[x] | S Σ | 0..1 | |

doseRange | Range | ||

doseQuantity | SimpleQuantity | ||

rate[x] | S Σ | 0..1 | |

rateRatio | Ratio | ||

rateRange | Range | ||

rateQuantity | SimpleQuantity | ||

maxDosePerPeriod | Σ I | 0..1 | Ratio |

maxDosePerAdministration | Σ I | 0..1 | SimpleQuantity |

maxDosePerLifetime | Σ I | 0..1 | SimpleQuantity |

**ValueSets**

Valuesets are provided with ATC and OPS codes for some medications.

Canonical: https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-snomed

## ValueSet 'DrugTherapySnomed'

Version | 1.0.6 |

Published by | Berlin Institute of Health at Charité (BIH) |

Status | Active |

Experimental | False |

Pharmacological therapy in the context of Covid-19, relevant SNOMED-Codes

### Contact Information

Website: https://www.bihealth.org/en/re...

This value set includes codes from the following code systems:- The following codes from system: SNOMED_CT
Code Display 768759001 Product containing steroid (product) 413591007 Product containing atazanavir (medicinal product) 424096001 Product containing darunavir (medicinal product) 14728000 Product containing chloroquine (medicinal product) 83490000 Product containing hydroxychloroquine (medicinal product) 96138006 Product containing ivermectin (medicinal product) 134573001 Product containing lopinavir and ritonavir (medicinal product) 78025001 Product containing ganciclovir (medicinal product) 386142008 Product containing oseltamivir (medicinal product) 870518005 Product containing remdesivir (medicinal product) 35063004 Product containing ribavirin (medicinal product) 444649004 Product containing tocilizumab (medicinal product) 763522001 Product containing sarilumab (medicinal product) 416587008 Product containing calcineurin inhibitor (product) 416897008 Product containing tumor necrosis factor alpha inhibitor (product) 430817009 Product containing interleukin 1 receptor antagonist (product) 703779004 Product containing ruxolitinib (medicinal product) 73133000 Product containing colchicine (medicinal product) 768865007 Product containing interferon (product) 88519001 Product containing calcifediol (medicinal product) 764877006 Product containing zinc (medicinal product) 1187214003 Product containing camostat (medicinal product) 1172871009 Product containing favipiravir (medicinal product) 1184610009 Convalescent plasma (product) 1162706008 Product containing casirivimab and imdevimab (medicinal product) 763701005 Product containing baricitinib (medicinal product) 704316006 Product containing tofacitinib (medicinal product) 1162693002 Product containing sotrovimab (medicinal product) 108693005 Product containing ritonavir (medicinal product) 96034006 Product containing azithromycin (medicinal product) 395279009 Product containing anakinra (medicinal product) 108622005 Product containing budesonide (medicinal product) 416739001 Product containing ciclesonide (medicinal product) 96213009 Product containing fluvoxamine (medicinal product) 46123006 Product containing ascorbic acid (medicinal product) 108943009 Product containing colecalciferol (medicinal product) 59187003 Product containing dopamine (medicinal product) 26523005 Product containing dobutamine (medicinal product) 108480007 Product containing milrinone (medicinal product) 442790008 Product containing levosimendan (medicinal product) 65502005 Product containing epinephrine (medicinal product) 111130009 Product containing norepinephrine (medicinal product) 772208008 Product containing antidiuretic hormone (medicinal product) 54765002 Product containing phenylephrine (medicinal product)

Canonical: https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-atc

## ValueSet 'DrugTherapyATC'

Version | 1.0.6 |

Published by | Berlin Institute of Health at Charité (BIH) |

Status | Active |

Experimental | False |

Pharmacological therapy in the context of Covid-19

### Contact Information

Website: https://www.bihealth.org/en/re...

This value set includes codes from the following code systems:- Include codes from Atc where concept IsA N02B
- Include codes from Atc where concept IsA G01B
- Include codes from Atc where concept IsA H02
- Include codes from Atc where concept IsA M01BA
- Include codes from Atc where concept IsA R03AK
- Include codes from Atc where concept IsA R03AL
- Include codes from Atc where concept IsA S02B
- Include codes from Atc where concept IsA L04AD
- Include codes from Atc where concept IsA L04AB
- Include codes from Atc where concept IsA L04AC
- Include codes from Atc where concept IsA L03AB
- Include codes from Atc where concept IsA A12CB
- Include codes from Atc where concept IsA A11G
- Include codes from Atc where concept IsA C03XA
- The following codes from system: Atc
Code Display D01AC20 Imidazole/Triazole in Kombination mit Corticosteroiden J05AE03 Ritonavir J05AE08 Atazanavir J05AR15 Atazanavir und Cobicistat J05AR23 Atazanavir und Ritonavir J05AE10 Darunavir J05AR14 Darunavir und Cobicistat J05AR22 Emtricitabin, Tenofoviralafenamid, Darunavir und Cobicistat P01BA01 Chloroquin P01BA02 Hydroxychloroquin P02CF01 Ivermectin D11AX22 Ivermectin J05AR10 Lopinavir und Ritonavir J05AB06 Ganciclovir S01AD09 Ganciclovir J05AH02 Oseltamivir J05AP01 Ribavirin B02AB04 Camostat J05AX27 Favipiravir S01XA18 Ciclosporin D11AH01 Tacrolimus L04AA10 Sirolimus L04AA18 Everolimus L04AA29 Tofacitinib L04AA37 Baricitinib L01XE10 Everolimus L01XE18 Ruxolitinib M04AC01 Colchicin S01AD05 Interferon A11CC06 Calcifediol J01FA10 Azithromycin J01RA07 Azithromycin, Fluconazol und Secnidazol S01AA26 Azithromycin R03BA02 Budesonid R03AK07 Formoterol und Budesonid R03AK12 Salmeterol und Budesonid R03BA08 Ciclesonid N06AB08 Fluvoxamin C01CA04 Dopamin C01CA07 Dobutamin C01CE02 Milrinon C01CX08 Levosimendan C01CA24 Epinephrin C01CA03 Norepinephrin C01CA06 Phenylephrin - Include codes from Atc where concept IsA A11G
- Include codes from Atc where concept IsA C03XA
- The following codes from system: Atc
Code Display N02B ANDERE ANALGETIKA UND ANTIPYRETIKA N02BA Salicylsäure und Derivate N02BA01 Acetylsalicylsäure N02BA02 Aloxiprin N02BA03 Cholinsalicylat N02BA04 Natriumsalicylat N02BA05 Salicylamid N02BA06 Salsalat N02BA07 Ethenzamid N02BA08 Morpholinsalicylat N02BA09 Dipyrocetyl N02BA10 Benorilat N02BA11 Diflunisal N02BA12 Kaliumsalicylat N02BA13 Lysin-Acetylsalicylat N02BA14 Guacetisal N02BA15 Carbasalat calcium N02BA16 Imidazolsalicylat N02BA19 Cholin-Magnesium-Tris-Salicylat N02BA20 Kombinationen N02BA51 Acetylsalicylsäure, Kombinationen exkl. Psycholeptika N02BA55 Salicylamid, Kombinationen exkl. Psycholeptika N02BA57 Ethenzamid, Kombinationen exkl. Psycholeptika N02BA59 Dipyrocetyl, Kombinationen exkl. Psycholeptika N02BA65 Carbasalat calcium, Kombinationen exkl. Psycholeptika N02BA71 Acetylsalicylsäure, Kombinationen mit Psycholeptika N02BA75 Salicylamid, Kombinationen mit Psycholeptika N02BA77 Ethenzamid, Kombinationen mit Psycholeptika N02BA79 Dipyrocetyl, Kombinationen mit Psycholeptika N02BB Pyrazolone N02BB01 Phenazon N02BB02 Metamizol-Natrium N02BB03 Aminophenazon N02BB04 Propyphenazon N02BB05 Nifenazon N02BB06 Phenazonsalicylat N02BB51 Phenazon, Kombinationen exkl. Psycholeptika N02BB52 Metamizol-Natrium, Kombinationen exkl. Psycholeptika N02BB53 Aminophenazon, Kombinationen exkl. Psycholeptika N02BB54 Propyphenazon, Kombinationen exkl. Psycholeptika** N02BB56 Phenazonsalicylat, Kombinationen exkl. Psycholeptika N02BB71 Phenazon, Kombinationen mit Psycholeptika N02BB72 Metamizol-Natrium, Kombinationen mit Psycholeptika N02BB73 Aminophenazon, Kombinationen mit Psycholeptika N02BB74 Propyphenazon, Kombinationen mit Psycholeptika N02BB76 Phenazonsalicylat, Kombinationen mit Psycholeptika N02BE Anilide N02BE01 Paracetamol N02BE03 Phenacetin N02BE04 Bucetin N02BE05 Propacetamol N02BE51 Paracetamol, Kombinationen exkl. Psycholeptika N02BE53 Phenacetin, Kombinationen exkl. Psycholeptika N02BE54 Bucetin, Kombinationen exkl. Psycholeptika N02BE61 Paracetamol, Kombinationen mit Coffein N02BE71 Paracetamol, Kombinationen mit Psycholeptika N02BE73 Phenacetin, Kombinationen mit Psycholeptika N02BE74 Bucetin, Kombinationen mit Psycholeptika N02BG Andere Analgetika und Antipyretika N02BG02 Rimazolium N02BG03 Glafenin N02BG04 Floctafenin N02BG05 Viminol N02BG06 Nefopam N02BG07 Flupirtin N02BG08 Ziconotid N02BG09 Methoxyfluran N02BG10 Cannabinoide N02BG11 Mirogabalin N02BG12 Tanezumab N02BH Homöopathische und anthroposophische Analgetika und Antipyretika N02BH01 Aconitum N02BH10 Verschiedene N02BH20 Kombinationen N02BP Pflanzliche Analgetika und Antipyretika N02BP01 Blauer Eisenhut N02BP02 Lindenblüten G01B ANTIINFEKTIVA/ANTISEPTIKA IN KOMBINATION MIT CORTICOSTEROIDEN G01BA Antibiotika und Corticosteroide G01BA01 Antibiotika und Corticosteroide G01BC Chinolin-Derivate und Corticosteroide G01BD Antiseptika und Corticosteroide G01BD01 Antiseptika und Corticosteroide G01BE Sulfonamide und Corticosteroide G01BE50 Sulfonamide und Corticosteroide, Kombinationen mit Antibiotika G01BF Imidazol-Derivate und Corticosteroide H02 CORTICOSTEROIDE ZUR SYSTEMISCHEN ANWENDUNG H02A CORTICOSTEROIDE ZUR SYSTEMISCHEN ANWENDUNG, REIN H02AA Mineralocorticoide H02AA01 Aldosteron H02AA02 Fludrocortison H02AA03 Desoxycorton H02AB Glucocorticoide H02AB01 Betamethason H02AB02 Dexamethason H02AB03 Fluocortolon H02AB04 Methylprednisolon H02AB05 Paramethason H02AB06 Prednisolon H02AB07 Prednison H02AB08 Triamcinolon H02AB09 Hydrocortison H02AB10 Cortison H02AB11 Prednyliden H02AB12 Rimexolon H02AB13 Deflazacort H02AB14 Cloprednol H02AB15 Meprednison H02AB17 Cortivazol H02AB51 Betamethason-Depot H02AB54 Methylprednisolon-Depot H02AB56 Prednisolon-Depot H02AB58 Triamcinolon-Depot H02B CORTICOSTEROIDE ZUR SYSTEMISCHEN ANWENDUNG, KOMBINATIONEN H02BX Corticosteroide zur systemischen Anwendung, Kombinationen H02BX01 Methylprednisolon, Kombinationen H02BX02 Dexamethason, Kombinationen H02BX06 Prednisolon, Kombinationen H02BX08 Triamcinolon, Kombinationen H02BX09 Betamethason, Kombinationen H02BX20 Kombinationen H02BX21 Desoxycorton, Kombinationen H02C NEBENNIERENHEMMSTOFFE H02CA Anticorticosteroide H02CA01 Trilostan H02CA02 Osilodrostat H02CA03 Ketoconazol M01BA Antiphlogistika/Antirheumatika in Kombination mit Corticosteroiden M01BA01 Phenylbutazon und Corticosteroide M01BA02 Dipyrocetyl und Corticosteroide M01BA03 Acetylsalicylsäure und Corticosteroide M01BA04 Mofebutazon und Corticosteroide M01BA05 Oxyphenbutazon und Corticosteroide M01BA06 Salicylamid und Corticosteroide M01BA07 Metamizol und Corticosteroide M01BA08 Kebuzon und Corticosteroide R03AK Sympathomimetika in Kombination mit Corticosteroiden oder anderen Mitteln, exkl. Anticholinergika R03AK01 Epinephrin und andere Mittel bei obstruktiven Atemwegserkrankungen R03AK02 Isoprenalin und andere Mittel bei obstruktiven Atemwegserkrankungen R03AK03 Fenoterol und Cromoglicinsäure, Dinatriumsalz R03AK04 Salbutamol und Cromoglicinsäure, Dinatriumsalz R03AK05 Reproterol und Cromoglicinsäure, Dinatriumsalz R03AK06 Salmeterol und Fluticason R03AK07 Formoterol und Budesonid R03AK08 Formoterol und Beclometason R03AK09 Formoterol und Mometason R03AK10 Vilanterol und Fluticasonfuroat R03AK11 Formoterol und Fluticason R03AK12 Salmeterol und Budesonid R03AK13 Salbutamol und Beclometason R03AK14 Indacaterol und Mometason R03AL Sympathomimetika in Kombination mit Anticholinergika inkl. Dreifachkombinationen mit Corticosteroiden R03AL01 Fenoterol und Ipratropiumbromid R03AL02 Salbutamol und Ipratropiumbromid R03AL03 Vilanterol und Umeclidiniumbromid R03AL04 Indacaterol und Glycopyrroniumbromid R03AL05 Formoterol und Aclidiniumbromid R03AL06 Olodaterol und Tiotropiumbromid R03AL07 Formoterol und Glycopyrroniumbromid R03AL08 Vilanterol, Umeclidiniumbromid und Fluticasonfuroat R03AL09 Formoterol, Glycopyrroniumbromid und Beclometason S02B CORTICOSTEROIDE S02BA Corticosteroide S02BA01 Hydrocortison S02BA03 Prednisolon S02BA06 Dexamethason S02BA07 Betamethason S02BA08 Fluocinolonacetonid S02BA56 Dexamethason, Kombinationen L04AD Calcineurin-Inhibitoren L04AD01 Ciclosporin L04AD02 Tacrolimus L04AD03 Voclosporin L04AB Tumornekrosefaktor alpha(TNF-alpha)-Inhibitoren L04AB01 Etanercept L04AB02 Infliximab L04AB03 Afelimomab L04AB04 Adalimumab L04AB05 Certolizumab pegol L04AB06 Golimumab L04AB07 Opinercept L04AC Interleukin-Inhibitoren L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC05 Ustekinumab L04AC07 Tocilizumab L04AC08 Canakinumab L04AC09 Briakinumab L04AC10 Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab L04AC19 Satralizumab L04AC20 Netakimab L04AC21 Bimekizumab L03AB Interferone L03AB01 Interferon alfa, natürlich L03AB02 Interferon beta, natürlich L03AB03 Interferon gamma L03AB04 Interferon alfa-2a L03AB05 Interferon alfa-2b L03AB06 Interferon alfa-n1 L03AB07 Interferon beta-1a L03AB08 Interferon beta-1b L03AB09 Interferon alfacon-1 L03AB10 Peginterferon alfa-2b L03AB11 Peginterferon alfa-2a L03AB12 Albinterferon alfa-2b L03AB13 Peginterferon beta-1a L03AB14 Cepeginterferon alfa-2b L03AB15 Ropeginterferon alfa-2b L03AB18 Interferon gamma-1b L03AB60 Peginterferon alfa-2b, Kombinationen L03AB61 Peginterferon alfa-2a, Kombinationen A12CB Zink A12CB01 Zinksulfat A12CB02 Zinkgluconat A12CB03 Zinkprotein-Komplex A12CB05 Zinkhydrogenaspartat A12CB06 Zinkorotat D01AC20 Imidazole/Triazole in Kombination mit Corticosteroiden J05AB16 Remdesivir J05AE03 Ritonavir J05AE08 Atazanavir J05AR15 Atazanavir und Cobicistat J05AR23 Atazanavir und Ritonavir J05AE10 Darunavir J05AR14 Darunavir und Cobicistat J05AR22 Emtricitabin, Tenofoviralafenamid, Darunavir und Cobicistat P01BA01 Chloroquin P01BA02 Hydroxychloroquin P02CF01 Ivermectin D11AX22 Ivermectin J05AR10 Lopinavir und Ritonavir J05AB06 Ganciclovir S01AD09 Ganciclovir J05AH02 Oseltamivir J05AP01 Ribavirin B02AB04 Camostat J05AX27 Favipiravir S01XA18 Ciclosporin D11AH01 Tacrolimus L04AA10 Sirolimus L04AA18 Everolimus L04AA29 Tofacitinib L04AA37 Baricitinib L01XE10 Everolimus L01XE18 Ruxolitinib M04AC01 Colchicin S01AD05 Interferon A11CC06 Calcifediol J01FA10 Azithromycin J01RA07 Azithromycin, Fluconazol und Secnidazol S01AA26 Azithromycin R03BA02 Budesonid R03AL11 Formoterol, Glycopyrroniumbromid und Budesonid R03BA08 Ciclesonid N06AB08 Fluvoxamin C01CA04 Dopamin C01CA07 Dobutamin C01CE02 Milrinon C01CX08 Levosimendan C01CA24 Epinephrin C01CA03 Norepinephrin C01CA06 Phenylephrin - Include codes from Atc where concept IsA N02B
- Include codes from Atc where concept IsA G01B
- Include codes from Atc where concept IsA H02
- Include codes from Atc where concept IsA M01BA
- Include codes from Atc where concept IsA R03AK
- Include codes from Atc where concept IsA R03AL
- Include codes from Atc where concept IsA S02B
- Include codes from Atc where concept IsA L04AD
- Include codes from Atc where concept IsA L04AB
- Include codes from Atc where concept IsA L04AC
- Include codes from Atc where concept IsA L03AB
- Include codes from Atc where concept IsA A12CB
- Include codes from Atc where concept IsA A11G
- Include codes from Atc where concept IsA C03XA
- The following codes from system: Atc
Code Display D01AC20 Imidazole/Triazole in Kombination mit Corticosteroiden J05AB16 Remdesivir J05AE03 Ritonavir J05AE08 Atazanavir J05AR15 Atazanavir und Cobicistat J05AR23 Atazanavir und Ritonavir J05AE10 Darunavir J05AR14 Darunavir und Cobicistat J05AR22 Emtricitabin, Tenofoviralafenamid, Darunavir und Cobicistat P01BA01 Chloroquin P01BA02 Hydroxychloroquin P02CF01 Ivermectin D11AX22 Ivermectin J05AR10 Lopinavir und Ritonavir J05AB06 Ganciclovir J05AB18 Molnupiravir S01AD09 Ganciclovir J05AH02 Oseltamivir J05AP01 Ribavirin B02AB04 Camostat J05AX27 Favipiravir S01XA18 Ciclosporin D11AH01 Tacrolimus L04AA10 Sirolimus L04AA18 Everolimus L04AA29 Tofacitinib L04AA37 Baricitinib L01EG02 Everolimus L01EJ01 Ruxolitinib M04AC01 Colchicin S01AD05 Interferon A11CC06 Calcifediol J06BD03 Tixagevimab und Cilgavimab J06BD05 Sotrovimab J06BD07 Casirivimab und Imdevimab J01FA10 Azithromycin J01RA07 Azithromycin, Fluconazol und Secnidazol S01AA26 Azithromycin R03BA02 Budesonid R03AK07 Formoterol und Budesonid R03AK12 Salmeterol und Budesonid R03AL11 Formoterol, Glycopyrroniumbromid und Budesonid R03BA08 Ciclesonid N06AB08 Fluvoxamin C01CA04 Dopamin C01CA07 Dobutamin C01CE02 Milrinon C01CX08 Levosimendan C01CA24 Epinephrin C01CA03 Norepinephrin C01CA06 Phenylephrin

Canonical: https://www.netzwerk-universitaetsmedizin.de/fhir/ValueSet/pharmacological-therapy-ops

## ValueSet 'DrugTherapyOPS'

Version | 1.0.6 |

Published by | Berlin Institute of Health at Charité (BIH) |

Status | Active |

Experimental | False |

Pharmacological therapy in the context of Covid-19, relevant OPS-Codes

### Contact Information

Website: https://www.bihealth.org/en/re...

This value set includes codes from the following code systems:- The following codes from system: OPS
Code Display 6-00a.g Sarilumab, parenteral 6-005.8 Everolimus, oral 6-005.7 Certolizumab, parenteral 6-005.2 Golimumab, parenteral 6-006.7 Canakinumab, parenteral 6-009.4 Ruxolitinib, oral - Include codes from OPS where concept IsA 6-005.m
- Include codes from OPS where concept IsA 6-005.n
- Include codes from OPS where concept IsA 6-004.e
- Include codes from OPS where concept IsA 6-001.d
- Include codes from OPS where concept IsA 6-002.b
- Include codes from OPS where concept IsA 6-001.e
- The following codes from system: OPS
Code Display 6-00a.g Sarilumab, parenteral 6-005.8 Everolimus, oral 6-005.7 Certolizumab, parenteral 6-005.2 Golimumab, parenteral 6-006.7 Canakinumab, parenteral 6-009.4 Ruxolitinib, oral - Include codes from OPS where concept IsA 6-005.m
- Include codes from OPS where concept IsA 6-005.n
- Include codes from OPS where concept IsA 6-004.e
- Include codes from OPS where concept IsA 6-001.d
- Include codes from OPS where concept IsA 6-002.b
- Include codes from OPS where concept IsA 6-001.e
- The following codes from system: OPS
Code Display 6-00a.g Sarilumab, parenteral 6-005.8 Everolimus, oral 6-005.7 Certolizumab, parenteral 6-005.2 Golimumab, parenteral 6-006.7 Canakinumab, parenteral 6-009.4 Ruxolitinib, oral - Include codes from OPS where concept IsA 6-005.m
- Include codes from OPS where concept IsA 6-005.n
- Include codes from OPS where concept IsA 6-004.e
- Include codes from OPS where concept IsA 6-001.d
- Include codes from OPS where concept IsA 6-002.b
- Include codes from OPS where concept IsA 6-001.e

**Examples**

**Patient is taking atazanavir**

{ "resourceType": "MedicationStatement", "id": "pharmacological-therapy-atazanavir-active", "meta": { "profile": [ "https://www.netzwerk-universitaetsmedizin.de/fhir/StructureDefinition/pharmacological-therapy" ] }, "status": "active", "medicationCodeableConcept": { "coding": [ { "code": "413591007", "system": "http://snomed.info/sct", "display": "Product containing atazanavir (medicinal product)" }, { "code": "J05AE08", "system": "http://fhir.de/CodeSystem/bfarm/atc", "display": "Atazanavir" } ], "text": "Atazanavir" }, "subject": { "reference": "Patient/gecco-patient" }, "effectiveDateTime": "2020-10-19T08:43:33+02:00" }